Skip to main content
SpringerLink
Log in

Diagnosis of Benign Prostatic Hyperplasia

  • Chapter
  • First Online:
Prostatic Artery Embolization

Abstract

Benign prostatic hyperplasia (BPH) can lead to lower urinary tract symptoms (LUTS), which can have a significant impact on a patient’s quality of life. BPH is most easily identified on physical exam with digital rectal examination (DRE), as well as transrectal ultrasound or MRI. The size of the prostate does not correlate well to the degree of LUTS in all patients, however. Objective measurements of a patient’s urinary symptoms include the AUA-SI and IPSS templates. Urinalysis, postvoid residual (PVR), and uroflow should be performed in the clinic setting during the evaluation of BPH. Routine laboratory evaluation is not indicated in the standard patient that presents with LUTS thought to be secondary to BPH. However, in some clinical scenarios, a PSA and renal ultrasound may be appropriate. Urodynamic studies should be considered in patients with equivocal findings on noninvasive studies. Routine cystoscopic evaluation is not recommended during the initial workup of LUTS secondary to BPH, but may be offered if surgical treatment is being considered. Transrectal ultrasound volume measurements are the most widely accepted measurements of prostate volume. Upper urinary tract imaging is not recommended in the routine evaluation of men with LUTS unless hematuria, UTI, renal insufficiency, or history of urolithiasis or UTI is present.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AUA-SI:

American Urological Association-Symptom Index

BOO:

Bladder outlet obstruction

BPH:

Benign prostatic hyperplasia

DOA:

Detrusor overactivity

DRE:

Digital rectal examination

IPSS:

International Prostate Symptom Scores

LUTS:

Lower urinary tract symptoms

PVR:

Postvoid residual

QOL:

Quality of life

TRUS:

Transrectal ultrasound

TURP:

Transurethral resection of the prostate

References

  1. Lee C, Kozlowski JM, Grayhack JT. Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate. 1997;31(2):131–8.

    Article  CAS  Google Scholar 

  2. Auffenberg GB, Helfand BT, McVary KT. Established medical therapy for benign prostatic hyperplasia. Urol Clin North Am. 2009;36(4):443–59, v–vi.

    Article  Google Scholar 

  3. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256–61.

    Article  Google Scholar 

  4. McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care. 2006;12(5 Suppl):S122–8.

    PubMed  Google Scholar 

  5. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387–98.

    Article  CAS  Google Scholar 

  6. O’Leary MP. Lower urinary tract symptoms/benign prostatic hyperplasia: maintaining symptom control and reducing complications. Urology. 2003;62(3 Suppl 1):15–23.

    Article  Google Scholar 

  7. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803.

    Article  Google Scholar 

  8. Bosch JL, Bohnen AM, Groeneveld FP, Bernsen R. Validity of three calliper-based transrectal ultrasound methods and digital rectal examination in the estimation of prostate volume and its changes with age: the Krimpen study. Prostate. 2005;62(4):353–63.

    Article  CAS  Google Scholar 

  9. Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM, et al. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology. 1997;49(4):548–57.

    Article  CAS  Google Scholar 

  10. Simonsen O, Moller-Madsen B, Dorflinger T, Norgaard JP, Jorgensen HS, Lundhus E. The significance of age on symptoms and urodynamic- and cystoscopic findings in benign prostatic hypertrophy. Urol Res. 1987;15(6):355–8.

    Article  CAS  Google Scholar 

  11. Roehrborn CG, Chinn HK, Fulgham PF, Simpkins KL, Peters PC. The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy. J Urol. 1986;135(6):1190–3.

    Article  CAS  Google Scholar 

  12. Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 2017;197(2S):S189–S97.

    Article  Google Scholar 

  13. Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med Care. 1995;33(4 Suppl):AS145–55.

    CAS  PubMed  Google Scholar 

  14. Weiss JP. Nocturia: “do the math”. J Urol. 2006;175(3 Pt 2):S16–8.

    PubMed  Google Scholar 

  15. Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J, International Consultation on New Developments in Prostate C, et al. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2013;189(1 Suppl):S93–S101.

    CAS  PubMed  Google Scholar 

  16. McConnell JD, Barry MJ, Bruskewitz RC. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin. 1994;(8):1–17.

    Google Scholar 

  17. Jensen KM, Bruskewitz RC, Iversen P, Madsen PO. Spontaneous uroflowmetry in prostatism. Urology. 1984;24(4):403–9.

    Article  CAS  Google Scholar 

  18. Jensen KM, Jorgensen JB, Mogensen P. Urodynamics in prostatism. I. Prognostic value of uroflowmetry. Scand J Urol Nephrol. 1988;22(2):109–17.

    Article  CAS  Google Scholar 

  19. McLoughlin J, Gill KP, Abel PD, Williams G. Symptoms versus flow rates versus urodynamics in the selection of patients for prostatectomy. Br J Urol. 1990;66(3):303–5.

    Article  CAS  Google Scholar 

  20. Chancellor MB, Blaivas JG, Kaplan SA, Axelrod S. Bladder outlet obstruction versus impaired detrusor contractility: the role of outflow. J Urol. 1991;145(4):810–2.

    Article  CAS  Google Scholar 

  21. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014;65(2):389–98.

    Article  Google Scholar 

  22. Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J, International Scientific C. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2009;181(4):1779–87.

    Article  CAS  Google Scholar 

  23. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118–40.

    Article  Google Scholar 

  24. Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol. 1979;51(2):129–34.

    Article  CAS  Google Scholar 

  25. Jensen KM, Andersen JT. Urodynamic implications of benign prostatic hyperplasia. Urologe A. 1990;29(1):1–4.

    CAS  PubMed  Google Scholar 

  26. Jones C, Hill J, Chapple C, Guideline Development Group. Management of lower urinary tract symptoms in men: summary of NICE guidance. BMJ. 2010;340:c2354.

    Article  Google Scholar 

  27. Gosling JA, Dixon JS. Structure of trabeculated detrusor smooth muscle in cases of prostatic hypertrophy. Urol Int. 1980;35(5):351–5.

    Article  CAS  Google Scholar 

  28. Gosling JA, Gilpin SA, Dixon JS, Gilpin CJ. Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction. J Urol. 1986;136(2):501–4.

    Article  CAS  Google Scholar 

  29. Sech S, Montoya J, Girman CJ, Rhodes T, Roehrborn CG. Interexaminer reliability of transrectal ultrasound for estimating prostate volume. J Urol. 2001;166(1):125–9.

    Article  CAS  Google Scholar 

  30. Kaplan SA. Update on the American urological association guidelines for the treatment of benign prostatic hyperplasia. Rev Urol. 2006;8(Suppl 4):S10–7.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of North Carolina Hospitals, Chapel Hill, NC, USA

    Matthew R. Macey & Mathew C. Raynor

Authors
  1. Matthew R. Macey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mathew C. Raynor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew R. Macey .

Editor information

Editors and Affiliations

  1. Department of Radiology, University of North Carolina, School of Medicine, Chapel Hill, NC, USA

    Ari J. Isaacson

  2. Vascular and Interventional Radiology, Vascular Institute of Virginia, Woodbridge, VA, USA

    Sandeep Bagla

  3. Department of Urology, University of North Carolina Hospitals, Chapel Hill, NC, USA

    Mathew C. Raynor

  4. Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina, School of Medicine, Chapel Hill, NC, USA

    Hyeon Yu

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Macey, M.R., Raynor, M.C. (2020). Diagnosis of Benign Prostatic Hyperplasia. In: Isaacson, A., Bagla, S., Raynor, M., Yu, H. (eds) Prostatic Artery Embolization. Springer, Cham. https://doi.org/10.1007/978-3-030-23471-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-23471-3_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-23470-6

  • Online ISBN: 978-3-030-23471-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation